title: A phase II trial of TCNU in patients with squamous, adeno and large cell carcinoma of the lung.
authors.affiliation: Department of Oncology, Finsen Institute, Copenhagen, Denmark.
authors.forename: J
authors.initials: J
authors.lastname: Vibe-Petersen
authors.forename: F
authors.initials: F
authors.lastname: Bach
authors.forename: A G
authors.initials: AG
authors.lastname: Pedersen
authors.forename: J
authors.initials: J
authors.lastname: Smyth
authors.forename: H H
authors.initials: HH
authors.lastname: Hansen
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D018288:Carcinoma, Small Cell / Q000188:drug therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013654:Taurine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds; D013654:Taurine; C052991:1-(2-chloroethyl)-3-(2-(dimethylaminosulfonyl)ethyl)-1-nitrosourea